Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01
LivaNova to Present at J.P. Morgan Healthcare Conference in January
LivaNova to Present at J.P. Morgan Healthcare Conference in January
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026
Clinical trial for MDM2 amplified cancers expected to commence in second half of 2021NEWARK, Calif., June 03, 2021 (GLOBE NEWSWIRE)...
Company details multi-year Joint Preservation strategy for accelerated revenue growth and profitability Updates 2021 directional outlook and 2024 multi-year targets BEDFORD,...
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH...
CELEBRATION, Fla., June 03, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and...
Financing significantly bolsters liquidity position to support continued investment in growth of telehealth businessNEW YORK, June 03, 2021 (GLOBE NEWSWIRE)...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR...
DENVER, June 03, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’),...
Ocugen to have exclusive co-development, manufacturing, and commercialization rights to COVAXIN™ in Canada, in addition to its existing US rightsMALVERN,...
Entering field of RNA therapeutics through acquisition of Trasir Therapeutics, Inc.Trasir’s innovative peptide-based OligoPhoreTM platform designed to enable extrahepatic delivery...
COPENHAGEN, Denmark, June 03, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotech company developing AI-driven immunotherapies...
Studies demonstrate value of MRD in novel treatment settings including CAR T cell therapy and in a growing range of...
Company Expects to Advance First Intranasally Administered IgM Antibody, IGM-6268, into the Clinic in Third Quarter of 2021MOUNTAIN VIEW, Calif.,...
- Principal Repayments Delayed At Least Until January 1, 2022 - Repayment Delay and Recent ATM Activity Extends Cash Runway...
High rate of complete responses in RP1 skin cancer cohorts underscore the potential for profound patient benefit and supports the...
TORONTO, June 03, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a...
MSP-1014 selected based on head-to-head comparison to psilocybin and its active metabolite psilocin MSP-1014 showed greater safety and efficacy in...
VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
Toronto, Ontario--(Newsfile Corp. - June 3, 2021) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the...
CHICAGO--(BUSINESS WIRE)--GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and participation in the ACC’s...
Key highlights include a plenary session on cervical cancer among women in developing nations and an oral abstract exploring molecular...
